Search results
Tech Bytes: Moderna partners with OpenAI to expedite drug development processes
Proactive Investors· 3 days agoModerna, the biotechnology firm best known for its COVID-19 vaccines, has partnered with artificial...
Moderna, Inc. (NASDAQ:MRNA) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 5 days agoModerna, Inc. (NASDAQ:MRNA) Q1 2024 Earnings Call Transcript May 2, 2024 Moderna, Inc. beats...
Moderna reports $1.2bn net loss in Q1 2024
Pharmaceutical Technology via Yahoo Finance· 7 days agoNet product sales plummeted by 91% compared to Q1 2023. This downturn aligns with the expected transition to a seasonal market for Covid-19 vaccines....
AstraZeneca pulls its COVID-19 vaccine from the European market
Atlanta Journal-Constitution· 2 days agoThe pharma giant AstraZeneca has requested that the European authorization for its COVID-19 vaccine...
AstraZeneca withdraws Covid-19 jab from the market
PA Media: Science via Yahoo News· 2 days ago“There would have been far more deaths, hospitalisations, illness and transmission, if we hadn’t had the AstraZeneca vaccine, alongside the other key ...
A 'Decline in Demand' Leads to the End for This COVID Vaccine
newser· 1 day agoMore than 3 billion doses of the vaccine were administered in other countries around the world...
AstraZeneca withdraws Covid-19 vaccine, citing low demand
CNN Business via Yahoo Finance· 1 day agoAstraZeneca is withdrawing its highly successful coronavirus vaccine, citing the availability of a...
Moderna, Inc. (NASDAQ:MRNA) Expected to Earn Q3 2025 Earnings of $1.30 Per Share
ETF DAILY NEWS· 4 days agoModerna, Inc. (NASDAQ:MRNA – Free Report) – Equities research analysts at William Blair lifted their Q3 2025 EPS estimates for Moderna in a report released ...
AstraZeneca to withdraw COVID-19 vaccine worldwide due to low demand
KOAA5· 1 day agoDrugmaker AstraZeneca is reportedly pulling its COVID-19 vaccine from global markets due to a...
Royal Bank of Canada Increases Moderna (NASDAQ:MRNA) Price Target to $135.00
ETF DAILY NEWS· 5 days agoModerna (NASDAQ:MRNA – Get Free Report) had its target price lifted by Royal Bank of Canada from $125.00 to $135.00 in a report issued on Friday, Benzinga reports. Royal Bank ...
